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Abstract The expression of type XVI collagen in various phases
of cell growth in cultured skin fibroblasts was studied. A marked
increase in type XVI collagen mRNA level was found in
stationary phases of cell growth (non-adherent and confluent
phases), whereas the expression of type I and III collagens was
undetectable in the non-adherent phase but became greater in the
confluent phase. When suspended cells were further cultured over
72 h (suspension arrest), mRNA level and gene transcription of
type XVI collagen were time-dependently increased whereas
those of type I collagen remained undetectable. When the
confluent cells were further cultured for 72 h under the condition
of serum deprivation (serum deprivation arrest), mRNA levels of
both type XVI collagen and type I collagen were elevated. The
level of type XVI collagen polypeptide in the culture media of
suspension-arrested and serum deprivation-arrested cells paral-
leled the mRNA level of type XVI collagen. The results indicate
that expression of type XVI collagen (a member of the fibril-
associated collagens with interrupted triple helices), unlike
interstitial collagens (type I collagen), is related to cell growth
arrest brought about by two different growth inhibiting systems,
suspension arrest and serum deprivation arrest.
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1. Introduction
Collagen, a major constituent of connective tissue, is a large
family of proteins with distinct tissue distributions and func-
tions [1,2]. On the basis of their structure and function, the
collagens are generally divided into two categories: the ¢bril-
forming collagens and the non-¢bril-forming collagens. The
¢bril-forming collagens such as type I, II, III, V and VI
have long central triple-helical domains with Gly-X-Y repeat-
ing sequences and form highly organized ¢brils in a quarter-
staggered fashion. Type I and III collagens are major extra-
cellular collagens in the skin (interstitial collagens). The latter
classes of collagens are very heterogeneous in size and have
imperfections in the Gly-X-Y repeating sequences as a com-
mon feature. Type IX, XII and XIV collagens form a sub-
group named the ¢bril-associated collagens with interrupted
triple helices (FACIT) [3].
The gene of type XVI collagen has been isolated from hu-
man ¢broblast and placenta cDNA libraries. The predicted
polypeptide, designated K1(XVI), consists of 10 collagenous
domains which are interspersed with 11 non-collagenous do-
mains exhibiting several structural features characteristically
seen in members of FACIT and cuticle collagens of nema-
todes [4,5]. However, no information on the physiological
function of type XVI collagen has been available.
The proliferation of connective tissue cells including skin
¢broblasts in culture is strongly dependent on attachment to
a solid surface, which has been called anchorage dependence
[6^8]. Attached cells spread, move out, and grow to colonize
the surface. Upon adhesion, cells synthesize and deposit their
own extracellular matrix components to spread and prolifer-
ate e⁄ciently on the culture dishes. For example, it has been
reported that adhesion of mouse 3T3 ¢broblasts to plastic
dishes results in the induction of growth-associated genes
(c-fos and c-myc) and type I collagen gene, a major interstitial
collagen [9,10]. To determine the functional role of type XVI
collagen in cell adhesion and proliferation, we have studied
the expression of type XVI collagen as well as type I and III
collagens in the various phases of cell growth: non-adherent,
attaching, spreading, proliferating and con£uent phases.
2. Materials and methods
2.1. Fibroblast culture
Normal human skin ¢broblasts were explanted from the skin ob-
tained from the normal portion of benign skin tumors. The cultures
were maintained in Dulbecco’s modi¢ed Eagle’s medium (DMEM)
supplemented with 10% fetal bovine serum (FBS) and sodium bicar-
bonate (3.7 g/l) in a humidi¢ed atmosphere of 5% CO2 in air at 37‡C.
Cells of the third or fourth culture were used in this experiment. Non-
adherent cells were obtained by trypsin treatment (0.05%) of 50%
con£uent cells (corresponding to day 3 in culture, see below) followed
by suspension in DMEM containing 10% FBS for 10 min. To study
the growth kinetics, the non-adherent cells were plated at a density of
2.2U104 cell/cm2 in 35 or 100 mm diameter tissue culture dishes, and
cultured in DMEM supplemented with 10% FBS for 6 h, 1, 3 or
8 days. At the end of the culture periods, the number and the shape
of the cells were observed with an optical microscope. To bring cells
to quiescence, the non-adherent cells obtained from day 3 in culture
were suspended in 0.1% methylcellulose (4000 cP, Sigma, St. Louis,
MO, USA) dissolved in DMEM containing 10% FBS at a density of
1.5U105 cells/ml [11] and cultured for 24, 48 or 72 h at 37‡C (sus-
pension arrest), or cultures of con£uent cells on day 8 were placed
under the condition of serum starvation (0.5% FBS) for 0, 24, 48 or
72 h (serum deprivation arrest).
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2.2. Ribonuclease protection and Northern blot assays
Ribonuclease protection assays were performed to quantitatively
determine the steady-state level of speci¢c K1(XVI) mRNA in dermal
¢broblasts, because K1(XVI) mRNA signals were hardly detected by
Northern blot assays. The fragment (BamHI/PstI, 604 bp) containing
the N-terminal non-collagenous region of K1(XVI) collagen (NC11
domain) [4,5] was subcloned into pGEM vector (Promega, Madison,
WI, USA). Antisense RNA probes were transcribed from the template
sequences with T7 RNA polymerase and labeled with [K-32P]UTP
(16 TBq/mmol, Amersham) according to the supplier’s protocol
(Promega). Full-length transcripts were puri¢ed from acrylamide
(6% acrylamide/8 M urea) gel and used as probes. The probes were
hybridized with sample RNAs isolated from cultured ¢broblasts [12]
at 42‡C overnight, then digested with RNase A (10 U/ml) and RNase
T1 (2000 U/ml) (Ambion, Austin, TX, USA) at 37‡C for 3 h. The
protected RNA fragments were analyzed on sequence gel (6% acryl-
amide/8 M urea) and exposed to X-ray ¢lms [13]. Northern blot
analysis was performed as previously described [5]. RNA was resolved
on 1% agarose gel electrophoresis and blotted onto nylon membranes.
The blots were hybridized with 32P-labeled probes (V108 cpm/Wg
DNA). Human pro-K1(I) (Hf 677) [14], pro-K2(I) (Hf32) [15], pro-
K1(III) (Hf 934) [16] and glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) [17] cDNAs were labeled with [32P]dCTP (110 TBq/mmol,
Amersham). The ¢lters were washed and exposed to X-ray ¢lm. The
£uorograms were scanned with a densitometer.
2.3. Nuclear run-o¡ assay
To determine the transcriptional activity of the K1(XVI) gene, a
nuclear run-o¡ assay was performed essentially as described previ-
ously [18]. Brie£y, nuclei were prepared from suspension-arrested cells
or actively proliferating cells (cells on day 3 in culture) according to
the method of Greenberg et al. [19]. The nuclei were incubated with
[K-32P]UTP (120 TBq/mmol, Amersham) for 20 min at 30‡C. The
samples were deproteinized, and the transcribed RNA was hybridized
with cDNAs at the concentration of V106 cpm/ml. One microgram
of cDNAs, pro-K2 (I) [16], K1 (XVI) [4,5], GAPDH [17] and pBR322
DNA was dot-blotted onto nitrocellulose ¢lters. After hybridization
the ¢lters were washed and subjected to autoradiography. Autoradio-
grams were scanned with a densitometer.
2.4. Detection of type XVI collagen polypeptide
Based on hydrophilicity characteristics [20], a sequence of 18 amino
acid residues, TQPTRRVFPRGLPEEFAL, in the N-terminal non-
triple-helical domain of K1(XVI) (NC11 domain) was selected for
antibody production. The antibody against the synthetic K1(XVI)
peptide was produced by intraperitoneal injection to rabbits and pu-
ri¢ed by protein A-TSK gel (Amersham). The peptide-speci¢c anti-
body was eluted from the peptide-agarose a⁄nity column with 0.1 M
citrate bu¡er, pH 3.0 [21].
Fibroblasts (day 3 in culture) were trypsinized and cultured in 10%
FBS^DMEM containing 0.1% methylcellulose for 48 h at 37‡C, then
cultured for 24 h (last 24 h during the 72 h culture) in fresh medium
(10% FBS^DMEM containing 0.1% methylcellulose). Con£uent cells
(day 8 in culture) were cultured in serum-deprived DMEM for 48 h.
Culture medium was replaced by fresh serum-deprived DMEM, then
cells were cultured for an additional 24 h (last 24 h during the 72 h
culture). For comparison, proliferating cells (day 3 in culture) were
incubated for 24 h with fresh DMEM containing 10% FBS. The
medium was harvested by centrifugation or aspiration, and mixed
with protease inhibitor cocktails (1 mM ethylenediamine tetraacetic
acid, N-ethylmaleimide and phenylmethylsulfonyl £uoride). The pro-
teins in the media were precipitated with 30% saturated ammonium
sulfate (176 mg/ml) and subjected to the analysis with 2^15% gradient
sodium dodecylsulfate^polyacrylamide gel electrophoresis (SDS^
PAGE) under reducing conditions, then blotted onto nitrocellulose
¢lters. The ¢lters were stained with the a⁄nity-puri¢ed antibody at
1/1000 dilution for 24 h. The blots were washed and incubated with
second antibody (anti-rabbit immunoglobulins) at 1/1000 dilution for
1 h. Antigens were visualized by chemiluminescence (ECL, Amer-
sham) [21]. DNA content in the cells was determined using £uoro-
metric assays as previously described [22]. To compare the amount of
K1(XVI) polypeptide in the proliferating, suspension-arrested and se-
rum deprivation-arrested cells, the amount of the samples for SDS^
PAGE was normalized to DNA content of the cell pellet.
3. Results
On optical microscopic observation, the cells of a round
shape were attaching to the plates at 6 h in culture. The cells
were spreading on day 1 in culture and had a skirt of cyto-
plasm and dark nuclei. On day 3, cells were exponentially
growing and they reached con£uent density on day 8. Deter-
mination of the K1(XVI) collagen mRNA level in the various
phases of cell growth; non-adherent, attaching (6 h in cul-
ture), spreading (1 day in culture), proliferating (day 3 in
culture) and con£uent (day 8 in culture) phases revealed
that the expression was highest in the conditions of non-ad-
herent and con£uent phases. In contrast, mRNA levels of
K1(I), K2(I) and K1(III) collagens were not detected in the
non-adherent phase but were elevated in the adhesive (attach-
ing and spreading) phases reaching maximum level in the
con£uent phase (Fig. 1).
To further investigate K1(XVI) collagen expression in the
stationary conditions, the non-adherent cells were incubated
in 0.1% methylcellulose dissolved with 10% FBS^DMEM over
Fig. 1. Modulation of K1(XVI) collagen expression in the various
phases of cell growth in cultured human skin ¢broblasts. Cells
grown to 50% con£uent density were suspended in DMEM contain-
ing 10% FBS after trypsin treatment (non-adherent phase). The
non-adherent cells were plated at a density of 2.2U104/cm2 in petri
dishes. Total RNA was extracted from the non-adherent cells or ad-
herent cells at 6 h (attaching phase), on day 1 (spreading phase),
day 3 (proliferating phase) or day 8 (con£uent phase) in culture.
The amount of mRNA for K1(XVI) was assayed by RNase protec-
tion assay and those of K1(I), K2(I), K1(III) and GAPDH by North-
ern blot analysis.
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72 h (suspension-arrested condition), or con£uent cells were
incubated in serum-deprived DMEM for 72 h (serum-de-
prived condition). A time-dependent increase of K1(XVI) col-
lagen mRNA during 72 h was found in both suspension-ar-
rested and serum-deprived conditions (Fig. 2a,b). The type
XVI collagen mRNA level in the suspension culture for 72 h
was found to be increased 11-fold compared with proliferating
cells (Fig. 2a). In contrast, the K2(I) mRNA level, which was
signi¢cant in the proliferating phase, became undetectable in
the suspension-arrested condition during a 72 h incubation
(Fig. 2a), whereas a time-dependent increase in K2(I) mRNA
was observed in the serum-deprived condition (Fig. 2b).
To determine the mechanism of the increase in K1(XVI)
mRNA in the suspension-arrested or serum deprivation-ar-
rested cells, the transcription of the K1(XVI) gene in the pro-
liferating, suspension-arrested and serum-deprived cells was
compared. The transcriptional activities of the K1(XVI) gene
in both suspension and serum-deprived cultures for 72 h were
found to be greater (¢ve-fold) than those in the actively pro-
liferating cells (day 3 in culture). By contrast, transcription of
the pro-K2(I) gene in the suspension-arrested cells was hardly
detectable but became greater in the proliferating and serum-
deprived cells (Fig. 3).
Major 210 kDa and minor 70 kDa polypeptides were de-
tected in the culture medium of the cells which had been
suspended for 72 h, whereas the polypeptides were hardly
detected in the proliferating cells. In the serum-deprived cells
for 72 h, 210 kDa and several 80^90 kDa polypeptides were
seen (Fig. 4). The minor 70 kDa and 80^90 kDa polypeptides
may be degraded products of the 210 kDa polypeptide, since
Fig. 2. Time-dependent increase in K1(XVI) expression in the
growth-arrested conditions brought about by two di¡erent systems.
Cells were grown to half-con£uent density, then treated with tryp-
sin. Non-adherent cells were suspended in 10% FBS^DMEM con-
taining 0.1% methylcellulose for 24, 48 and 72 h (suspension arrest).
For comparison, mRNA levels in the proliferating (50% con£uent)
cells were also studied (a). Cells were grown to a con£uent density
in DMEM supplemented with 10% FBS, then further cultured in se-
rum-free DMEM for 0, 24, 48 or 72 h (serum deprivation arrest)
(b). RNA was isolated from the cells, then K1(XVI), K2(I) and
GAPDH mRNA levels were determined.
Fig. 3. Transcriptional activity of the K1(XVI) gene in the proliferat-
ing, suspension-arrested or serum-deprived cells in culture. Nuclei
were isolated from actively proliferating cells (day 3 in culture), sus-
pension-arrested cells (72 h in suspension culture) or serum depriva-
tion-arrested con£uent cells (72 h in serum-deprived culture). Mes-
senger RNA precursors synthesized in vitro were labeled with
[32P]UTP, then hybridized with K1(XVI), GAPDH, pro-K2(I)
cDNAs and pBR322 DNA. The ¢lters were washed and subjected
to autoradiography.
Fig. 4. Detection of type XVI collagen polypeptide in the media of
proliferating, suspension-arrested or serum-deprived cells. Proliferat-
ing: proliferating cells (day 3 in culture) were cultured for 24 h in
fresh 10% FBS^DMEM. Suspension: cells were suspended in 0.1%
methylcellulose dissolved in DMEM containing 10% FBS for 72 h.
During the last 24 h of the 72 h culture, cells were cultured with
the same fresh medium. Serum-deprivation: cells at a con£uent den-
sity were cultured in serum-deprived DMEM for 72 h. During the
last 24 h of the 72 h culture, cells were cultured in fresh serum- de-
prived DMEM. Culture media obtained with these three di¡erent
conditions were harvested. The proteins in the media were precipi-
tated, resolved on 2^15% SDS^PAGE under reducing condition,
then transferred to nitrocellulose. The ¢lters were stained with a⁄n-
ity-puri¢ed anti-K1 (XVI) antibody at 1/1000 dilution for 24 h, then
with second antibody at 1/1000 dilution for 1 h. Antigens were de-
tected with chemiluminescence. Molecular standard markers are in-
dicated.
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intact K1(XVI) collagen with a molecular weight of 210 kDa
has been found to undergo proteolytic processing to several
lower molecular weight polypeptides in the culture medium
[23].
4. Discussion
We have demonstrated that type XVI collagen expression
was elevated in the non-adherent cells and was suppressed in
the attaching, spreading and proliferating conditions. This is
in a sharp contrast to type I/III collagens, expression of which
was undetectable in the non-adherent condition but enhanced
in the subsequent adhesive and proliferative phases. This sug-
gests that the expression of type XVI collagen may be anchor-
age-independent, while type I and III collagen expression is
anchorage-dependent.
When the actively proliferating cells (3 days in culture) were
dissociated from the culture dishes and maintained in the
suspension culture for 72 h, type XVI collagen mRNA level
was enhanced markedly (11-fold), but the degree of the in-
crease in mRNA level was greater than the increase in tran-
scriptional activity of the K1(XVI) collagen gene (¢ve-fold),
suggesting that the expression of type XVI collagen during
cell dissociation was regulated at transcriptional and post-
transcriptional levels.
Previous studies have demonstrated that the mRNA levels
of type I and III collagens were increased when growth of
¢broblasts was arrested at high cell density (density arrest),
or by serum deprivation [24^26]. The increase in type I and III
collagen expression has not been explained directly by the
entry of cells into a quiescent state but by the alteration in
the degree of cell^cell interaction with high cell density or by
the alteration of cell^matrix interaction accompanying the loss
of adhesive components (¢bronectin or vitronectin) in serum,
because type I and III collagen expression was found to be
very low in the suspension arrest in which the cells enter the
G0 phase within 48 h [9^11]. These previous observations on
type I and III collagen suggest that the mechanism of increase
in type XVI collagen in the growth arrest condition induced
by serum deprivation may be di¡erent from that of type I
collagen, although type XVI and type I collagen expressions
were coordinately increased in the serum-deprived conditions.
The expression of type XVI collagen was shown to be
markedly increased in two di¡erent growth inhibiting culture
systems induced by suspension arrest and serum deprivation
of con£uent cells, indicating that type XVI collagen (a mem-
ber of FACIT) expression, unlike type I and III collagens
(members of interstitial collagens), is grossly related to the
stationary phase of cell growth. In normal circumstances der-
mal ¢broblasts are considered to be in the stationary phase of
cell growth, but actively migrate and proliferate in in£amma-
tory or ¢brotic conditions. Type XVI collagen may play an
essential role in resting cells rather than proliferating cells by
stabilizing the placement of ¢broblasts in the dermal matrices.
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